Journals / Acta Medica Alanya / 2026 / Cilt: 5 Sayı: 2

Transcranial Magnetic stimulation in Psychiatry: Past, Current and Future

Psikiyatride Transkraniyal Manyetik Uyarım: Geçmiş, Şimdi ve Gelecek

Burak Yuluğ(ALANYA ALAADDIN KEYKUBAT UNIVERSITY, FACULTY OF MEDICINE)0000-0002-9704-6173
Ahmet Aslan(Alanya Alaaddin Keykubat Üniversitesi, Tıp Fakültesi)0000-0001-5797-1287
Pages
107–108
Publication Date
2021-08-30
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As a conclusion, rTMS seems to offer a potential for neuroprotective therapy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Transcranial Magnetic Stimulation (rTMS) is a novel non-invasive neuromodulation method applied via a coil to the skull surface of the patient stimulating relevant brain regions.
📊
Key Findings & Data:Replicating data suggest the therapeutic role of repetitive transcranial magnetic stimulation (rTMS) in many psychiatric diseases though there are limited human neuroprotective data.
💡
Conclusion & Impact:As a conclusion, rTMS seems to offer a potential for neuroprotective therapy.
🔬Design:Editoryal
📍Scope:Comprehensive Sample
⚙️Variables:Transkraniyal Manyetik Uyarım · Nöroproteksiyon · Psikiyatrik Hastalıklar

Abstract

Transcranial Magnetic Stimulation (rTMS) is a novel non-invasive neuromodulation method applied via a coil to the skull surface of the patient stimulating relevant brain regions. Replicating data suggest the therapeutic role of repetitive transcranial magnetic stimulation (rTMS) in many psychiatric diseases though there are limited human neuroprotective data. Here we aimed to evaluate the therapeutic role of rTMS from a multifaceted perspective, including its effects on the neuroplasticity and neuroprotection processes. As a conclusion, rTMS seems to offer a potential for neuroprotective therapy.

Özet

Transkraniyal Manyetik Uyarım (TMU), hastanın kafatası yüzeyine bir bobin aracılığıyla uygulanarak ilgili beyin bölgelerini uyaran yeni bir non-invaziv nöromodülasyon yöntemidir.insan çalışmalarında nöroprotektif etkisine dair kanıtlar sınırlı olsa da, yinelenen veriler, birçok psikiyatrik bozuklukta TMU’ nın terapötik rol oynadığını düşündürmektedir. Bu yazıda nöroplastisite ve nöroproteksiyonun süreçler üzerindeki etkileri de dahil olmak üzere, çok yönlü bir bakış açısıyla TMU'nın terapötik etkisini araştırdık. Sonuç olarak, TMU, nöroprotektif tedavi için bir potansiyel sunuyor gibi görünmektedir.

🔖

Cite This Article

Yuluğ, B., Aslan, A. (2021). Transcranial Magnetic stimulation in Psychiatry: Past, Current and Future. Acta Medica Alanya, Cilt: 5 Sayı: 2, 107–108. https://doi.org/10.30565/medalanya.985758

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Eschweiler G.W. (2003) Entwicklung der transkraniellen Magnetstimulation (TMS). In: Eschweiler G.W., Wild B., Bartels M. (eds) Elektromagnetische Therapien in der Psychiatrie. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57370-5_16
  2. Facharztwissen Psychiatrie, Psychosomatik und Psychotherapie (2017). Frank Schneider. Springer-Verlag GmbH Deutschland. https://doi.org/10.1007/978-3-662-50345-4
  3. Yulug B. Neuroprotective treatment strategies for poststroke mood disorders: A minireview on atypical neuroleptic drugs and selective serotonin re-uptake inhibitors. Brain Res Bull. 2009 Sep 28;80(3):95-9. doi: 10.1016/j.brainresbull.2009.06.013. Epub 2009 Jul 1. PMID: 19576272
  4. Caglayan B, Kilic E, Dalay A, et al. Allyl isothiocyanate attenuates oxidative stress and inflammation by modulating Nrf2/HO-1 and NF-κB pathways in traumatic brain injury in mice. Mol Biol Rep. 2019;46(1):241-250. doi:10.1007/s11033-018-4465-4
  5. Lapchak, Paul A., and John H. Zhang, eds. Neuroprotective therapy for stroke and ischemic disease. Switzerland: Springer International Publishing, 2017. doi:10.1007/978-3-319-45345-3
  6. Yulug B, Hanoglu L, Tavli AM, Yılmaz NH, Kılıc E. The Brain Protective Effect of rTMS (Repetitive Transcranial Magnetic Stimulation) in Depression: A Mini-Review in Animal Studies. Med Chem. 2016;12(6):500-505. doi:10.2174/1573406411666151005110321
  7. Yuluğ B, Ozan E, Kilic E. Brain-derived neurotrophic factor polymorphism as a genetic risk for depression? A short review of the literature. J Neuropsychiatry Clin Neurosci. 2010 Winter;22(1):123.E5-6. doi: 10.1176/jnp.2010.22.1.123.e5
  8. Yulug B, Hanoglu L, Khanmammadov E, et al. Beyond The Therapeutic Effect of rTMS in Alzheimer's Disease: A Possible Neuroprotective Role of Hippocampal BDNF?: A Minireview. Mini Rev Med Chem. 2018;18(17):1479-1485. doi:10.2174/1389557517666170927162537
  9. Yulug B, Hanoglu L, Khanmammadov E, et al. Beyond The Therapeutic Effect of rTMS in Alzheimer's Disease: A Possible Neuroprotective Role of Hippocampal BDNF?: A Minireview. Mini Rev Med Chem. 2018;18(17):1479-1485. doi:10.2174/1389557517666170927162537